Home > Healthcare & Medical Devices > Monoclonal Antibodies Market > Table of Contents

Monoclonal Antibodies Market Size By Type (Fully Human, Humanized, Chimeric), By Application (Oncology, Autoimmune Diseases, Infectious Diseases), By End-use (Hospitals, Specialty Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028

  • Report ID: GMI5065
  • Base Year: 2021
  • Report Format: PDF

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    Middle East & Africa

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1   Paid sources

1.5.1.2   Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Monoclonal antibodies industry 3600 synopsis

2.1.1    Business trends

2.1.2    Type trends

2.1.3    Application trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Monoclonal Antibodies Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 – 2028

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Increasing prevalence of chronic and infectious diseases worldwide

3.3.1.2   Growing research and development activities

3.3.1.3   High rate of adoption and approval in the U.S. and Europe

3.3.1.4   Booming biologics market

3.3.1.5   Rising applications of monoclonal antibodies

3.3.2    Industry pitfalls and challenges

3.3.2.1   High cost of some monoclonal antibody therapeutics

3.3.2.2   Stringent regulatory framework

3.4    Growth potential analysis

3.4.1    By type

3.4.2    By application

3.4.3    By end-use

3.5    Regulatory landscape

3.6    Future trends in monoclonal antibody-based therapeutics

3.7    Porter’s analysis

3.8    Competitive landscape, 2021

3.8.1    Company matrix analysis, 2021

3.8.2    Brand analysis

3.9    PESTEL analysis

Chapter 4   Monoclonal Antibodies Market, By Type

4.1    Key segment trends

4.2    Fully human

4.2.1    Market size, by region, 2017 – 2028 (USD Million)

4.3    Humanized

4.3.1    Market size, by region, 2017 – 2028 (USD Million)

4.4    Chimeric

4.4.1    Market size, by region, 2017 – 2028 (USD Million)

4.5    Others

4.5.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 5   Monoclonal Antibodies Market, By Application

5.1    Key segment trends

5.2    Oncology

5.2.1    Market size, by region, 2017 – 2028 (USD Million)

5.3    Autoimmune diseases

5.3.1    Market size, by region, 2017 – 2028 (USD Million)

5.4    Infectious diseases

5.4.1    Market size, by region, 2017 – 2028 (USD Million)

5.5    Others

5.5.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 6   Monoclonal Antibodies Market, By End-use

6.1    Key segment trends

6.2    Hospitals

6.2.1    Market size, by region, 2017 – 2028 (USD Million)

6.3    Specialty centers

6.3.1    Market size, by region, 2017 – 2028 (USD Million)

6.4    Others

6.4.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 7   Monoclonal Antibodies Market, By Region

7.1    Key regional trends

7.2    North America

7.2.1    Market size, by country, 2017 – 2028 (USD Mn)

7.2.2    Market size, by type, 2017 – 2028 (USD Mn)

7.2.3    Market size, by application, 2017 – 2028 (USD Mn)

7.2.4    Market size, by end-use, 2017 – 2028 (USD Mn)

7.2.5    U.S.

7.2.5.1   Market size, by type, 2017 – 2028 (USD Mn)

7.2.5.2   Market size, by application, 2017 – 2028 (USD Mn)

7.2.5.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.2.6    Canada

7.2.6.1   Market size, by type, 2017 – 2028 (USD Mn)

7.2.6.2   Market size, by application, 2017 – 2028 (USD Mn)

7.2.6.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.3    Europe

7.3.1    Market size, by country, 2017 – 2028 (USD Mn)

7.3.2    Market size, by type, 2017 – 2028 (USD Mn)

7.3.3    Market size, by application, 2017 – 2028 (USD Mn)

7.3.4    Market size, by end-use, 2017 – 2028 (USD Mn)

7.3.5    Germany

7.3.5.1   Market size, by type, 2017 – 2028 (USD Mn)

7.3.5.2   Market size, by application, 2017 – 2028 (USD Mn)

7.3.5.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.3.6    UK

7.3.6.1   Market size, by type, 2017 – 2028 (USD Mn)

7.3.6.2   Market size, by application, 2017 – 2028 (USD Mn)

7.3.6.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.3.7    France

7.3.7.1   Market size, by type, 2017 – 2028 (USD Mn)

7.3.7.2   Market size, by application, 2017 – 2028 (USD Mn)

7.3.7.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.3.8    Italy

7.3.8.1   Market size, by type, 2017 – 2028 (USD Mn)

7.3.8.2   Market size, by application, 2017 – 2028 (USD Mn)

7.3.8.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.3.9    Spain

7.3.9.1   Market size, by type, 2017 – 2028 (USD Mn)

7.3.9.2   Market size, by application, 2017 – 2028 (USD Mn)

7.3.9.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.4    Asia Pacific

7.4.1    Market size, by country, 2017 – 2028 (USD Mn)

7.4.2    Market size, by type, 2017 – 2028 (USD Mn)

7.4.3    Market size, by application, 2017 – 2028 (USD Mn)

7.4.4    Market size, by end-use, 2017 – 2028 (USD Mn)

7.4.5    China

7.4.5.1   Market size, by type, 2017 – 2028 (USD Mn)

7.4.5.2   Market size, by application, 2017 – 2028 (USD Mn)

7.4.5.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.4.6    Japan

7.4.6.1   Market size, by type, 2017 – 2028 (USD Mn)

7.4.6.2   Market size, by application, 2017 – 2028 (USD Mn)

7.4.6.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.4.7    India

7.4.7.1   Market size, by type, 2017 – 2028 (USD Mn)

7.4.7.2   Market size, by application, 2017 – 2028 (USD Mn)

7.4.7.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.4.8    Australia

7.4.8.1   Market size, by type, 2017 – 2028 (USD Mn)

7.4.8.2   Market size, by application, 2017 – 2028 (USD Mn)

7.4.8.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.4.9    Singapore

7.4.9.1   Market size, by type, 2017 – 2028 (USD Mn)

7.4.9.2   Market size, by application, 2017 – 2028 (USD Mn)

7.4.9.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.5    Latin America

7.5.1    Market size, by country, 2017 – 2028 (USD Mn)

7.5.2    Market size, by type, 2017 – 2028 (USD Mn)

7.5.3    Market size, by application, 2017 – 2028 (USD Mn)

7.5.4    Market size, by end-use, 2017 – 2028 (USD Mn)

7.5.5    Brazil

7.5.5.1   Market size, by type, 2017 – 2028 (USD Mn)

7.5.5.2   Market size, by application, 2017 – 2028 (USD Mn)

7.5.5.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.5.6    Mexico

7.5.6.1   Market size, by type, 2017 – 2028 (USD Mn)

7.5.6.2   Market size, by application, 2017 – 2028 (USD Mn)

7.5.6.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.5.7    Argentina

7.5.7.1   Market size, by type, 2017 – 2028 (USD Mn)

7.5.7.2   Market size, by application, 2017 – 2028 (USD Mn)

7.5.7.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.6    MEA

7.6.1    Market size, by country, 2017 – 2028 (USD Mn)

7.6.2    Market size, by type, 2017 – 2028 (USD Mn)

7.6.3    Market size, by application, 2017 – 2028 (USD Mn)

7.6.4    Market size, by end-use, 2017 – 2028 (USD Mn)

7.6.5    South Africa

7.6.5.1   Market size, by type, 2017 – 2028 (USD Mn)

7.6.5.2   Market size, by application, 2017 – 2028 (USD Mn)

7.6.5.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.6.6    Saudi Arabia

7.6.6.1   Market size, by type, 2017 – 2028 (USD Mn)

7.6.6.2   Market size, by application, 2017 – 2028 (USD Mn)

7.6.6.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.6.7    UAE

7.6.7.1   Market size, by type, 2017 – 2028 (USD Mn)

7.6.7.2   Market size, by application, 2017 – 2028 (USD Mn)

7.6.7.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.6.8    Egypt

7.6.8.1   Market size, by type, 2017 – 2028 (USD Mn)

7.6.8.2   Market size, by application, 2017 – 2028 (USD Mn)

7.6.8.3   Market size, by end-use, 2017 – 2028 (USD Mn)

7.6.9    Kuwait

7.6.9.1   Market size, by type, 2017 – 2028 (USD Mn)

7.6.9.2   Market size, by application, 2017 – 2028 (USD Mn)

7.6.9.3   Market size, by end-use, 2017 – 2028 (USD Mn)

Chapter 8   Company Profiles

8.1    Competitive dashboard, 2021

8.2    F. Hoffmann-La Roche Ltd.

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.2.5    SWOT analysis

8.3    AbbVie Inc.

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.3.5    SWOT analysis

8.4    Amgen

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.4.5    SWOT analysis

8.5    Bristol Myers Squibb

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6    Johnson & Johnson

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    Merck & Co., Inc.

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.7.5    SWOT analysis

8.8    Regeneron Pharmaceuticals Inc.

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.8.5    SWOT analysis

8.9    Novartis AG

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.9.5    SWOT analysis

8.10    AstraZeneca

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.10.5    SWOT analysis

8.11    Eli Lilly and Company

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

8.12    GlaxoSmithKline plc

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Product landscape

8.12.4    Strategic outlook

8.12.5    SWOT analysis

8.13    Takeda Pharmaceutical Company Limited

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Product landscape

8.13.4    Strategic outlook

8.13.5    SWOT analysis
 

Data Tables

TABLE 1.    Monoclonal antibodies market, 2017 – 2021 (USD Million)

TABLE 2.    Monoclonal antibodies market, 2022 – 2028(USD Million)

TABLE 3.    Monoclonal antibodies market, by type, 2017 – 2021 (USD Million)

TABLE 4.    Monoclonal antibodies market, by type, 2022 – 2028 (USD Million)

TABLE 5.    Monoclonal antibodies market, by application, 2017 – 2021 (USD Million)

TABLE 6.    Monoclonal antibodies market, by application, 2022 – 2028(USD Million)

TABLE 7.    Monoclonal antibodies market, by end-use, 2017 – 2021 (USD Million)

TABLE 8.    Monoclonal antibodies market, by end-use, 2022 – 2028(USD Million)

TABLE 9.    Monoclonal antibodies market, by region, 2017 – 2021 (USD Million)

TABLE 10.    Monoclonal antibodies market, by region, 2022 – 2028(USD Million)

TABLE 11.    Industry impact forces

TABLE 12.    Fully human market size, by region, 2017 – 2021 (USD Million)

TABLE 13.    Fully human market size, by region, 2022 – 2028(USD Million)

TABLE 14.    Humanized market size, by region, 2017 – 2021 (USD Million)

TABLE 15.    Humanized market size, by region, 2022 – 2028(USD Million)

TABLE 16.    Chimeric market size, by region, 2017 – 2021 (USD Million)

TABLE 17.    Chimeric market size, by region, 2022 – 2028(USD Million)

TABLE 18.    Others market size, by region, 2017 – 2021 (USD Million)

TABLE 19.    Others market size, by region, 2022 – 2028(USD Million)

TABLE 20.    Oncology market size, by region, 2017 – 2021 (USD Million)

TABLE 21.    Oncology market size, by region, 2022 – 2028(USD Million)

TABLE 22.    Autoimmune diseases market size, by region, 2017 – 2021 (USD Million)

TABLE 23.    Autoimmune diseases market size, by region, 2022 – 2028(USD Million)

TABLE 24.    Infectious diseases market size, by region, 2017 – 2021 (USD Million)

TABLE 25.    Infectious diseases market size, by region, 2022 – 2028(USD Million)

TABLE 26.    Others market size, by region, 2017 – 2021 (USD Million)

TABLE 27.    Others market size, by region, 2022 – 2028(USD Million)

TABLE 28.    Hospitals market size, by region, 2017 – 2021 (USD Million)

TABLE 29.    Hospitals market size, by region, 2022 – 2028(USD Million)

TABLE 30.    Specialty centers market size, by region, 2017 – 2021 (USD Million)

TABLE 31.    Specialty centers market size, by region, 2022 – 2028(USD Million)

TABLE 32.    Others market size, by region, 2017 – 2021 (USD Million)

TABLE 33.    Others market size, by region, 2022 – 2028(USD Million)

TABLE 34.    North America monoclonal antibodies market size, by country, 2017 – 2021 (USD Million)

TABLE 35.    North America monoclonal antibodies market size, by country, 2022 – 2028 (USD Million)

TABLE 36.    North America monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 37.    North America monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 38.    North America monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 39.    North America monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 40.    North America monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 41.    North America monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 42.    U.S. monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 43.    U.S. monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 44.    U.S. monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 45.    U.S. monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 46.    U.S. monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 47.    U.S. monoclonal antibodies market size, by End-use, 2022 – 2028 (USD Million)

TABLE 48.    Canada monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 49.    Canada monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 50.    Canada monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 51.    Canada monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 52.    Canada monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 53.    Canada monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 54.    Europe monoclonal antibodies market size, by country, 2017 – 2021 (USD Million)

TABLE 55.    Europe monoclonal antibodies market size, by country, 2022 – 2028 (USD Million)

TABLE 56.    Europe monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 57.    Europe monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 58.    Europe monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 59.    Europe monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 60.    Europe monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 61.    Europe monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 62.    Germany monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 63.    Germany monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 64.    Germany monoclonal antibodies market size, by application, type – 2020 (USD Million)

TABLE 65.    Germany monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 66.    Germany monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 67.    Germany monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 68.    UK monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 69.    UK monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 70.    UK monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 71.    UK monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 72.    UK monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 73.    UK monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 74.    France monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 75.    France monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 76.    France monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 77.    France monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 78.    France monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 79.    France monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 80.    Italy monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 81.    Italy monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 82.    Italy monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 83.    Italy monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 84.    Italy monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 85.    Italy monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 86.    Spain monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 87.    Spain monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 88.    Spain monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 89.    Spain monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 90.    Spain monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 91.    Spain monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 92.    Asia Pacific    monoclonal antibodies market size, by country, 2017 – 2021 (USD Million)

TABLE 93.    Asia Pacific    monoclonal antibodies market size, by country, 2022 – 2028 (USD Million)

TABLE 94.    Asia Pacific    monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 95.    Asia Pacific    monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 96.    Asia Pacific    monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 97.    Asia Pacific    monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 98.    Asia Pacific    monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 99.    Asia Pacific    monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 100.    Japan monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 101.    Japan monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 102.    Japan monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 103.    Japan monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 104.    Japan monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 105.    Japan monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 106.    China monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 107.    China monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 108.    China monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 109.    China monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 110.    China monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 111.    China monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 112.    India monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 113.    India monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 114.    India monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 115.    India monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 116.    India monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 117.    India monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 118.    Australia monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 119.    Australia monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 120.    Australia monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 121.    Australia monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 122.    Australia monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 123.    Australia monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 124.    Singapore monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 125.    Singapore monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 126.    Singapore monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 127.    Singapore monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 128.    Singapore monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 129.    Singapore monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 130.    Latin America monoclonal antibodies market size, by country, 2017 – 2021 (USD Million)

TABLE 131.    Latin America monoclonal antibodies market size, by country, 2022 – 2028 (USD Million)

TABLE 132.    Latin America monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 133.    Latin America monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 134.    Latin America monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 135.    Latin America monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 136.    Latin America monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 137.    Latin America monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 138.    Brazil monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 139.    Brazil monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 140.    Brazil monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 141.    Brazil monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 142.    Brazil monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 143.    Brazil monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 144.    Mexico monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 145.    Mexico monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 146.    Mexico monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 147.    Mexico monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 148.    Mexico monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 149.    Mexico monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 150.    Argentina monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 151.    Argentina monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 152.    Argentina monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 153.    Argentina monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 154.    Argentina monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 155.    Argentina monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 156.    MEA monoclonal antibodies market size, by country, 2017 – 2021 (USD Million)

TABLE 157.    MEA monoclonal antibodies market size, by country, 2022 – 2028 (USD Million)

TABLE 158.    MEA monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 159.    MEA monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 160.    MEA monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 161.    MEA monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 162.    MEA monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 163.    MEA monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 164.    South Africa monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 165.    South Africa monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 166.    South Africa monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 167.    South Africa monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 168.    South Africa monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 169.    South Africa monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 170.    Saudi Arabia monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 171.    Saudi Arabia monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 172.    Saudi Arabia monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 173.    Saudi Arabia monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 174.    Saudi Arabia monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 175.    Saudi Arabia monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 176.    UAE monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 177.    UAE monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 178.    UAE monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 179.    UAE monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 180.    UAE monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 181.    UAE monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 182.    Egypt monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 183.    Egypt monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 184.    Egypt monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 185.    Egypt monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 186.    Egypt monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 187.    Egypt monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

TABLE 188.    Kuwait monoclonal antibodies market size, by type, 2017 – 2021 (USD Million)

TABLE 189.    Kuwait monoclonal antibodies market size, by type, 2022 – 2028 (USD Million)

TABLE 190.    Kuwait monoclonal antibodies market size, by application, 2017 – 2021 (USD Million)

TABLE 191.    Kuwait monoclonal antibodies market size, by application, 2022 – 2028 (USD Million)

TABLE 192.    Kuwait monoclonal antibodies market size, by end-use, 2017 – 2021 (USD Million)

TABLE 193.    Kuwait monoclonal antibodies market size, by end-use, 2022 – 2028 (USD Million)

   

Charts & Figures

FIG. 1    Monoclonal antibodies industry 3600 synopsis

FIG. 2    Industry segmentation

FIG. 3    Global monoclonal antibodies market, 2017 - 2028 (USD Million)

FIG. 4    Growth potential analysis, by type

FIG. 5    Growth potential analysis, by application

FIG. 6    Growth potential analysis, by end-use

FIG. 7    Porter's analysis

FIG. 8    Company matrix analysis, 2021

FIG. 9    Brand analysis

FIG. 10    PESTEL analysis

FIG. 11    Key segment trends, by type

FIG. 12    Key segment trends, by application

FIG. 13    Key segment trends, by end-use

FIG. 14    Key regional trends

FIG. 15    Competitive dashboard, 2021
 

Authors: Sumant Ugalmugle, Rupali Swain

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Published Date: May 2022
  • Companies covered: 13
  • Tables & Figures: 208
  • Countries covered: 20
  • Pages: 160

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount